Shao Rui Chen

What is he best known for?

The fields of study he is best known for:

• Internal medicine
• Neurotransmitter
• Neuron

Shao Rui Chen focuses on Chemistry, Endocrinology, Internal medicine, Neuroscience and Neuropathic pain. His studies in Endocrinology integrate themes in fields like Neurotransmission, Ischemia and Resiniferatoxin. His study in the field of CATS, Artery and Heterotrimeric G protein also crosses realms of Hypercapnia and Sodium lactate.

Shao Rui Chen combines subjects such as DAMGO, Muscarinic acetylcholine receptor, Nociceptor and Opioid with his study of Neuroscience. Neuropathic pain is a primary field of his research addressed under Anesthesia. Shao Rui Chen usually deals with Excitatory postsynaptic potential and limits it to topics linked to Long-term potentiation and Postsynaptic potential and Hyperalgesia.

His most cited work include:

• Gabapentin Suppresses Ectopic Nerve Discharges and Reverses Allodynia in Neuropathic Rats (174 citations)
• Cardiac vanilloid receptor 1‐expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats (172 citations)
• Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition (145 citations)

What are the main themes of his work throughout his whole career to date?

Shao Rui Chen spends much of his time researching Chemistry, Neuroscience, Internal medicine, Neuropathic pain and Endocrinology. His Chemistry study spans across into areas like Excitatory postsynaptic potential, Inhibitory postsynaptic potential, Glutamate receptor, Pharmacology and Anatomy. His Neuroscience study incorporates themes from Long-term potentiation, Glutamatergic, Posterior Horn Cell and Neurotransmission.

His study in the fields of Receptor, Potassium channel and CATS under the domain of Internal medicine overlaps with other disciplines such as Sympathetic nervous system. His Neuropathic pain research is multidisciplinary, relying on both Dorsal root ganglion, Spinal cord, Nerve injury and Nociception. As part of one scientific family, he deals mainly with the area of Endocrinology, narrowing it down to issues related to the Muscarinic acetylcholine receptor, and often Acetylcholine and Cholinergic.

He most often published in these fields:

• Chemistry (48.21%)
• Neuroscience (42.86%)
• Internal medicine (37.50%)

What were the highlights of his more recent work (between 2017-2020)?

• Dorsal root ganglion (23.21%)
• Neuropathic pain (36.61%)
• Glutamate receptor (21.43%)

In recent papers he was focusing on the following fields of study:

Shao Rui Chen mainly investigates Dorsal root ganglion, Neuropathic pain, Glutamate receptor, Nociception and Synaptic plasticity. His Dorsal root ganglion research includes elements of Nerve injury and Pharmacology. Within one scientific family, he focuses on topics pertaining to Chronic pain under Neuropathic pain, and may sometimes address concerns connected to Cancer research, Muscarinic acetylcholine receptor and Muscarine.

In his research, Shao Rui Chen undertakes multidisciplinary study on Glutamate receptor and Chemistry. His work carried out in the field of Synaptic plasticity brings together such families of science as Neuroscience and Neurotransmission. His Neuroscience research is multidisciplinary, incorporating elements of Long-term potentiation and Glutamatergic.

Between 2017 and 2020, his most popular works were:

• The α2δ-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions (81 citations)
• Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root Ganglion. (25 citations)
• μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia. (23 citations)